Free public records show Cytrellis Biosystems, Inc. in 1 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Cytrellis Biosystems, Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
4 active studies led by Cytrellis Biosystems, Inc., of 10 in all
Source: ClinicalTrials.gov, Studies with Cytrellis Biosystems, Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
2 510(k) clearances and PMA approvals since 2015
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
Studies Cytrellis Biosystems, Inc. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Cytrellis Biosystems, Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Cytrellis Biosystems, Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Cytrellis Biosystems, Inc. is in.
Stories on the topics Cytrellis Biosystems, Inc. works in.
Collagen powders promise younger skin and easier joints. A 2025 review of 23 trials found the benefits…
Read
Skin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions…
Read
More than 300 million operations are done each year, and many no longer need an overnight stay. Ambulatory…
ReadSearch all reports for Cytrellis Biosystems, Inc. All companies